Logo image of MXL

MAXLINEAR INC (MXL) Stock Fundamental Analysis

NASDAQ:MXL - Nasdaq - US57776J1007 - Common Stock - Currency: USD

11.67  -0.67 (-5.43%)

After market: 11.67 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MXL. MXL was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. MXL may be in some trouble as it scores bad on both profitability and health. MXL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MXL has reported negative net income.
In the past year MXL has reported a negative cash flow from operations.
In multiple years MXL reported negative net income over the last 5 years.
Of the past 5 years MXL 4 years had a positive operating cash flow.
MXL Yearly Net Income VS EBIT VS OCF VS FCFMXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.03%, MXL is doing worse than 83.64% of the companies in the same industry.
MXL has a Return On Equity of -45.14%. This is amonst the worse of the industry: MXL underperforms 82.73% of its industry peers.
Industry RankSector Rank
ROA -26.03%
ROE -45.14%
ROIC N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
MXL Yearly ROA, ROE, ROICMXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

The Gross Margin of MXL (55.19%) is better than 74.55% of its industry peers.
MXL's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MXL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
MXL Yearly Profit, Operating, Gross MarginsMXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

MXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
MXL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MXL has more shares outstanding
MXL has a worse debt/assets ratio than last year.
MXL Yearly Shares OutstandingMXL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MXL Yearly Total Debt VS Total AssetsMXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.09, we must say that MXL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.09, MXL is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
MXL has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
MXL has a Debt to Equity ratio (0.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACCN/A
WACC10.09%
MXL Yearly LT Debt VS Equity VS FCFMXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

MXL has a Current Ratio of 1.63. This is a normal value and indicates that MXL is financially healthy and should not expect problems in meeting its short term obligations.
MXL has a Current ratio of 1.63. This is amonst the worse of the industry: MXL underperforms 81.82% of its industry peers.
A Quick Ratio of 1.19 indicates that MXL should not have too much problems paying its short term obligations.
MXL has a worse Quick ratio (1.19) than 82.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.19
MXL Yearly Current Assets VS Current LiabilitesMXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

MXL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -568.75%.
Looking at the last year, MXL shows a very negative growth in Revenue. The Revenue has decreased by -33.12% in the last year.
Measured over the past years, MXL shows a small growth in Revenue. The Revenue has been growing by 2.59% on average per year.
EPS 1Y (TTM)-568.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.19%
Revenue 1Y (TTM)-33.12%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%0.7%

3.2 Future

The Earnings Per Share is expected to grow by 48.64% on average over the next years. This is a very strong growth
MXL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.54% yearly.
EPS Next Y130.41%
EPS Next 2Y69.84%
EPS Next 3Y48.64%
EPS Next 5YN/A
Revenue Next Year23.61%
Revenue Next 2Y21.44%
Revenue Next 3Y18.54%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MXL Yearly Revenue VS EstimatesMXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MXL Yearly EPS VS EstimatesMXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 14.50, MXL is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MXL indicates a somewhat cheap valuation: MXL is cheaper than 78.18% of the companies listed in the same industry.
MXL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.13.
Industry RankSector Rank
PE N/A
Fwd PE 14.5
MXL Price Earnings VS Forward Price EarningsMXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MXL Per share dataMXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MXL's earnings are expected to grow with 48.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.84%
EPS Next 3Y48.64%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MXL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXLINEAR INC

NASDAQ:MXL (6/13/2025, 8:25:00 PM)

After market: 11.67 0 (0%)

11.67

-0.67 (-5.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-22 2025-07-22/amc
Inst Owners83.59%
Inst Owner Change0.75%
Ins Owners6.63%
Ins Owner Change1.01%
Market Cap1.01B
Analysts72
Price Target15.35 (31.53%)
Short Float %7.38%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.38%
Min EPS beat(2)-3.14%
Max EPS beat(2)29.89%
EPS beat(4)1
Avg EPS beat(4)-2.7%
Min EPS beat(4)-27.3%
Max EPS beat(4)29.89%
EPS beat(8)4
Avg EPS beat(8)-3.13%
EPS beat(12)7
Avg EPS beat(12)-0.98%
EPS beat(16)11
Avg EPS beat(16)0.91%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-0.01%
Max Revenue beat(2)1.51%
Revenue beat(4)2
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-8.96%
Max Revenue beat(4)1.51%
Revenue beat(8)3
Avg Revenue beat(8)-1.9%
Revenue beat(12)3
Avg Revenue beat(12)-1.61%
Revenue beat(16)6
Avg Revenue beat(16)-1.1%
PT rev (1m)-18.87%
PT rev (3m)-32.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-58.7%
EPS NY rev (1m)-25.14%
EPS NY rev (3m)-25.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.5
P/S 2.79
P/FCF N/A
P/OCF N/A
P/B 2.04
P/tB 8.19
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)0.8
Fwd EY6.9%
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS4.18
BVpS5.71
TBVpS1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.03%
ROE -45.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.19%
FCFM N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
F-Score2
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.41%
Cap/Sales 4.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.19
Altman-Z 1.09
F-Score2
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)51.53%
Cap/Depr(5y)53.82%
Cap/Sales(3y)5.32%
Cap/Sales(5y)5.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-568.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.19%
EPS Next Y130.41%
EPS Next 2Y69.84%
EPS Next 3Y48.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-33.12%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%0.7%
Revenue Next Year23.61%
Revenue Next 2Y21.44%
Revenue Next 3Y18.54%
Revenue Next 5YN/A
EBIT growth 1Y-51.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year191.66%
EBIT Next 3Y61.01%
EBIT Next 5YN/A
FCF growth 1Y-137.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.49%
OCF growth 3YN/A
OCF growth 5YN/A